Cited 0 times in
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.contributor.author | 박재준 | - |
dc.contributor.author | 천재영 | - |
dc.date.accessioned | 2021-05-21T16:42:10Z | - |
dc.date.available | 2021-05-21T16:42:10Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1598-9100 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/182530 | - |
dc.description.abstract | The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | Korean, English | - |
dc.publisher | Taehan Chang Yŏngu Hakhoe | - |
dc.relation.isPartOf | INTESTINAL RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Soo-Kyung Park | - |
dc.contributor.googleauthor | Chang Hwan Choi | - |
dc.contributor.googleauthor | Jaeyoung Chun | - |
dc.contributor.googleauthor | Heeyoung Lee | - |
dc.contributor.googleauthor | Eun Sun Kim | - |
dc.contributor.googleauthor | Jae Jun Park | - |
dc.contributor.googleauthor | Chan Hyuk Park | - |
dc.contributor.googleauthor | Bo-In Lee | - |
dc.contributor.googleauthor | Yunho Jung | - |
dc.contributor.googleauthor | Dong-Il Park | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.contributor.googleauthor | Hana Park | - |
dc.contributor.googleauthor | Yoon Tae Jeen | - |
dc.identifier.doi | 10.5217/ir.2019.09155 | - |
dc.contributor.localId | A00385 | - |
dc.contributor.localId | A01636 | - |
dc.contributor.localId | A05701 | - |
dc.relation.journalcode | J01182 | - |
dc.identifier.eissn | 1598-9100 | - |
dc.identifier.pmid | 32013312 | - |
dc.subject.keyword | Inflammatory bowel disease | - |
dc.subject.keyword | Prevention | - |
dc.subject.keyword | Vaccination | - |
dc.subject.keyword | Viral hepatitis | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.affiliatedAuthor | 김도영 | - |
dc.contributor.affiliatedAuthor | 박재준 | - |
dc.contributor.affiliatedAuthor | 천재영 | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 18 | - |
dc.citation.endPage | 33 | - |
dc.identifier.bibliographicCitation | INTESTINAL RESEARCH, Vol.18(1) : 18-33, 2020-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.